Clinical Trial Update: A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS). [Phase 1]

View source ↗

Summary

This is a completed Phase I trial evaluating Peptide T for neuropsychiatric complications of HIV/AIDS. The update notes preliminary efficacy signals observed in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Peptide T (peptide T)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: HIV Infections, Cognition Disorders | Phase 1 | Status: COMPLETED